In re Thorpe

2 Citing cases

  1. Smithkline Beecham Corp. v. Apotex Corp.

    439 F.3d 1312 (Fed. Cir. 2006)   Cited 282 times   3 Legal Analyses
    Holding arguments insufficiently developed in briefing are forfeited

    While the patent statute does not provide for product-by-process claims, the courts have long recognized the appropriateness of such claims. See, e.g., In re Thorpe, 777 F.2d 695, 697 (Fed. Cir. 1985); In re Brown, 59 C.C.P.A. 1036, 459 F.2d 531, 535 (1972); In re Steppan, 55 C.C.P.A. 791, 394 F.2d 1013, 1018 (1967). The purpose of product-by-process claims is to allow inventors to claim "an otherwise patentable product that resists definition by other than the process by which it is made."

  2. Smithkline Beecham Corporation v. Apotex Corporation

    Civil Action No. 99-CV-4304, No. 00-CV-4888, 01-CV-0159, 01-CV-2169, Civil Action No. 99-CV-2926, No. 00-CV-5953, 02-CV-1484, Civil Action No. 00-CV-1393, No. 00-CV-6464, 01-CV-2602, Civil Action No. 01-CV-1027, No. 01-CV-3364, 02-CV-8493, Civil Action No. 01-CV-2981, No. 03-CV-6117, Civil Action No. 03-CV-3365 (E.D. Pa. Jul. 16, 2004)   Cited 10 times

    In Scripps Clinic Research Found. v. Grenentech, the Federal Circuit held that "[s]ince claims must be construed the same way for validity and for infringement, the correct reading of product-by-process claims is that they are not limited to product prepared by the process set forth in the claims." 927 F.2d 1565, 1583 (Fed. Cir. 1991) (citing In re Thorpe, 777 F.2d 695 (Fed. Cir. 1985)). The following year, a different panel of the Federal Circuit decided Atlantic Thermoplastics Co., Inc. v. Faytex Corp., 970 F.2d 834 (Fed. Cir. 1992), reh'g en banc denied, 974 F.2d 1299.